Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer.

Brown, Aaron P; Pugh, Thomas J; Swanson, David A; Kudchadker, Rajat J; Bruno, Teresa L; Christensen, Eva N; van Vulpen, Marco; Frank, Steven J

Brown, Aaron P; Pugh, Thomas J; Swanson, David A; Kudchadker, Rajat J; Bruno, Teresa L; Christensen, Eva N; van Vulpen, Marco; Frank, Steven J.

Affiliation

Brown AP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Brachytherapy ; 12(5): 401-7, 2013.

Article in En | MEDLINE | ID: mdl-23380383

Subject(s)

Brachytherapy/methods; Magnetic Resonance Imaging/methods; Prostatic Neoplasms/radiotherapy; Tomography, X-Ray Computed/methods; Aged; Aged, 80 and over; Biopsy; Dose-Response Relationship, Radiation; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Prostatic Neoplasms/pathology; Radiometry/methods

Key words

Brachytherapy; Prostate cancer; Sector analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy / Magnetic Resonance Imaging / Tomography, X-Ray Computed Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Brachytherapy Journal subject: RADIOTERAPIA Year: 2013 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google